Ascending–descending aortic bypass with the aid of a heart-lifting device  by Krishnan, Ganapathy Subramaniam et al.
we continue to recommend rebiopsy of
the 2R, 4R, and 4L stations through thora-
cotomy or through video-assisted thoraco-
scopic surgery.
The authors’ second question concerns
the oxymoronic nature of the term standard-
ized uptake value or maximum standardized
uptake value (maxSUV). The authors state
that “maxSUV is not standardized among
different PET scanners and centers, mak-
ing comparison and adoption of the pro-
posed values by other institutions impossi-
ble.” We strongly but amicably disagree
with this statement. First, the percentage
change takes into account most of these
variables, and this is why we recommend
the repeat PET scan to be performed at the
same center using the same techniques as
the initial staging PET scan. Second, after
much investigation and discussion with
PET engineers, designers, and technicians,
as well as expert nuclear radiologists,
across the world, we are told that the dif-
ference in the maxSUV of a patient’s can-
cer on a PET scanner in Italy might only be
up to 20% different if the patient had been
scanned in Birmingham, Alabama. It is true
that 20% is not negligible, but this is the
upper end of the discrepancy. Many steps
have already been implemented to limit
these differences and to promote the stan-
dardization of the PET techniques and thus
the maxSUV values. Finally, because we
recognized this as a possible limitation to
the everyday clinical applicability of our
data, our future studies, some of which
have been completed, have focused on
ways to account for these differences. For
instance, in this article we use the percent-
age change of the maxSUV of the primary
tumor and of the involved mediastinal
lymph node. We also have studied the use of
the ratio of the maxSUV of the tumor to the
N2 nodes to help predict metastatic disease.
When that ratio is 0.6 or greater, there is an
85% chance the node is malignant, and this
holds true for many different centers.2 This
obviates the need for absolute values and
takes into account the differences in max-
SUVs across different centers. Finally, we
are also studying the ratio of the size of the
tumor to the maxSUV value of the tumor.
The third and final question posed con-
cerns the increasing use of endoscopic
ultrasonography–guided fine-needle aspi-
ration (EUS-FNA). We have studied and
written extensively on EUS-FNA3,4 and
have used it as our first line of biopsy for
N2 nodal biopsy in patients who have sus-
picious lymph nodes metastasis in posterior
(7, 8, and 9) stations. Since 2001, we have
used EUS-FNA first so as to reserve the
mediastinoscopy for after induction che-
moradiotherapy. We also use repeat EUS-
FNA in those patients as well, as we have
described in our articles. However, the au-
thors did not note the downside of this
strategy, which is that one might miss un-
suspected N3 disease initially by not using
mediastinoscopy. The incidence of unsus-
pected N3 disease is higher in patients with
multinodal N2 disease as well. Finally,
EUS-FNA is great for the 7, 8, and 9 sta-
tions but is blind in most endosonogra-
pher’s hands for the 2R, 4R, 2L, 5, and
6 stations. I greatly appreciate the authors’
thoughtful and insightful letter, and I agree
with the majority of their comments.
Robert J. Cerfolio, MD
Cardiothoracic Surgery
University of Alabama at Birmingham
Birmingham, AL
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Ascending– descending aortic
bypass with the aid of a
heart-lifting device
To the Editor:
We read with interest the article “Ascending–
descending aortic bypass with the aid of a
heart-lifting device” by Aris and associ-
ates.1 We had an opportunity to use the
technique in the management of a 15-year-
old girl. She had arch reconstruction with
pulmonary artery banding through a tho-
ractomy at the age of 8 months for type B
interruption with ventricular septal defect.
Six months after the procedure, she had
undergone pulmonary artery debanding
with ventricular septal defect closure. She
had narrowing across the arch repair site,
with a gradient of 80 mm Hg across the
stenosed segment and significant left ven-
tricular hypertrophy.
In view of her previous operation, it
was decided to perform ascending–de-
scending aortic bypass during cardiopul-
monary bypass with a beating heart. An
18-mm Dacron tube graft was anastomosed
to the descending aorta with a heart-lifting
device (Starfish 2; Medtronic, Inc, Minne-
apolis, Minn) to keep the ventricular mass
out of the way during the operation (Figure
1). The descending aorta was approached
from the posterior pericardium. The stays
on the margins of the pericardium can also
be used to provide additional retraction
during exposure. We placed the graft lat-
eral to the right atrium within the pericar-
dium because we considered that the lie of
the graft would be better in this position.
The patient had uneventful postoperative
recovery with no residual gradient between
the upper and lower limbs at the time of
discharge.
Other techniques have been described
for performing bypass in the management
of complex recoarctation. The lateral
isthmic bypass2 between the left subcla-
vian artery and the descending aorta has
the advantage of being an “anatomic”
bypass. The disadvantage of the tech-
nique in our patient was that it would
require a repeat thoracotomy, and there
Figure 1. Use of the Starfish 2 device
(Medtronic, Inc) for ascending–descending
aortic bypass for retracting the ventricle.
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was concern about the adequacy of the
subclavian artery as the inflow segment.
Moreover, we would be lacking the
safety afforded by cardiopulmonary by-
pass. Ascending– descending aortic by-
pass has also been described by using the
right thoracotomy approach.3
We believe that cardiopulmonary by-
pass provides safety in the presence of
significant left ventricular hypertrophy.
Use of a heart-lifting device makes the
operation simpler by freeing the assis-
tant’s hand and by enabling the proce-
dure to be performed with a beating
heart. Strategically placed pericardial
stays can also help in keeping the heart
mass out of the way during the proce-
dure.
Ganapathy Subramaniam Krishnan, MCh
Ravi Agarwal, MCh
Kotturathu M. Cherian, FRACS
Frontier Lifeline and Dr. K. M. Cherian
Heart Foundation
Mogappair, Chennai, India
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Reply to the Editor:
We thank Dr Krishnan and colleagues for
their letter, which proves that resourceful
surgeons can be found worldwide. They
report the use of a heart-lifting device to
perform an ascending–descending aortic
bypass in a 15-year-old girl with previous
aortic arch surgery. Because of previous
thoracotomy, as in our reported case,1 they
elected this type of bypass, which has been
increasingly used for reoperations in the
aortic arch and isthmus in view of its ex-
cellent long-term results.2 The figure in the
letter is almost identical to the one appear-
ing in our article, except for the fact that
they routed the graft around the right mar-
gin of the heart. Direction of the graft
should conform to the individual anatomy
encountered in each case. Again, the excel-
lent exposure achieved with the use of a
lifting device to retract the heart is shown
and demonstrates that there is no need to
have an assistant’s hand cramming the op-
erative field. This report enhances the fea-
sibility of the procedure and might help to
popularize it. We encourage surgeons to try
it and foresee that it will be performed
without the use of cardiopulmonary bypass
in selected cases.
Alejandro Aris, MD, PhD
Maria Luz Maestre, MD
Maria Teresa Subirana, MD
Hospital de la Santa Creui Sant Pau
Departments of Cardiac Surgery,
Anesthesiology and Cardiology
Barcelona, Spain
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